These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 66985

  • 1. Increased primary cell-mediated immunity in culture subsequent to adriamycin or daunorubicin treatment of spleen donor mice.
    Orsini F, Pavelic Z, Mihich E.
    Cancer Res; 1977 Jun; 37(6):1719-26. PubMed ID: 66985
    [Abstract] [Full Text] [Related]

  • 2. Cellular basis for adriamycin-induced augmentation of cell-mediated cytotoxicity in culture.
    Ehrke MJ, Ryoyama K, Cohen SA.
    Cancer Res; 1984 Jun; 44(6):2497-504. PubMed ID: 6426781
    [Abstract] [Full Text] [Related]

  • 3. Modulation of the cytotoxic response against allogeneic tumor cells in culture by adriamycin.
    Tomazic V, Ehrke MJ, Mihich E.
    Cancer Res; 1980 Aug; 40(8 Pt 1):2748-55. PubMed ID: 6248213
    [No Abstract] [Full Text] [Related]

  • 4. Augmentation of the development of immune responses of mice against allogeneic tumor cells after adriamycin treatment.
    Tomazic V, Ehrke MJ, Mihich E.
    Cancer Res; 1981 Sep; 41(9 Pt 1):3370-6. PubMed ID: 7260903
    [Abstract] [Full Text] [Related]

  • 5. In vitro induction of polyclonal killer T cells with 2-mercaptoethanol and the essential role of macrophages in this process.
    Igarashi T, Okada M, Kishimoto T, Yamamura Y.
    J Immunol; 1977 May; 118(5):1697-703. PubMed ID: 67145
    [Abstract] [Full Text] [Related]

  • 6. Characterization of suppressor cells in mice bearing syngeneic mastocytoma.
    Takei F, Levy JG, Kilburn DG.
    J Immunol; 1977 Feb; 118(2):412-7. PubMed ID: 65423
    [Abstract] [Full Text] [Related]

  • 7. Characterization and specificity of murine anti-tumor cytotoxic effector cells within an ascitic tumor.
    Biddison WE, Palmer JC, Alexander MA, Cowan EP, Manson LA.
    J Immunol; 1977 Jun; 118(6):2243-53. PubMed ID: 68083
    [No Abstract] [Full Text] [Related]

  • 8. Combined cytolytic effect of x irradiation and cell-mediated immune reactions on tumor cells in vitro.
    Song CW, Levitt SH.
    Radiology; 1974 Apr; 111(1):211-2. PubMed ID: 4205812
    [No Abstract] [Full Text] [Related]

  • 9. Specificity of rat xenogeneic cell-mediated cytolysis for the products of the K and D loci of the mouse H-2 complex.
    Burakoff SJ, Dorf ME, Benacerraf B.
    J Immunol; 1977 May; 118(5):1795-8. PubMed ID: 67147
    [Abstract] [Full Text] [Related]

  • 10. Role of host defense merchanisms in the antitumor activity of adriamycin and daunomycin in mice.
    Mantovani A, Polentarutti N, Luini W, Peri G, Spreafico F.
    J Natl Cancer Inst; 1979 Jul; 63(1):61-6. PubMed ID: 286835
    [No Abstract] [Full Text] [Related]

  • 11. Modulation of natural cytotoxicity by alloantibodies. I. Alloantisera enhancement of cytotoxicity of mouse spleen cells toward a human myeloid cell line.
    Saxena RK, Adler WH.
    J Immunol; 1979 Aug; 123(2):846-51. PubMed ID: 110883
    [Abstract] [Full Text] [Related]

  • 12. Effect of tumor cells on the generation of cytotoxic T lymphocytes in vitro. I. Accessory cell functions of mouse tumor cells in the generation of cytotoxic T lymphocytes in vitro: replacement of adherent phagocytic cells by tumor cells or 2-mercaptoethanol.
    Koren HS, Hodes RJ.
    Eur J Immunol; 1977 Jun; 7(6):394-400. PubMed ID: 302208
    [Abstract] [Full Text] [Related]

  • 13. Effector cell stimulation-inhibition of in vitro lymphoma cell DNA synthesis and correlation with in vivo antitumor response.
    Gordon WC, Prager MD.
    Cancer Res; 1977 Feb; 37(2):507-13. PubMed ID: 832275
    [Abstract] [Full Text] [Related]

  • 14. In vitro and in vivo cytotoxicity of adriamycin and daunomycin for murine macrophages.
    Mantovani A.
    Cancer Res; 1977 Mar; 37(3):815-20. PubMed ID: 837378
    [Abstract] [Full Text] [Related]

  • 15. The relation between the T cells responsible for cell-mediated cytotoxic killing of mastocytoma cells and the helper-cell effect.
    Igarashi T, Okada M, Kishimoto S, Yamamura Y.
    Immunology; 1975 Jan; 28(1):37-47. PubMed ID: 803916
    [Abstract] [Full Text] [Related]

  • 16. Destruction of experimental malignant melanoma by mediators of cellular immunity.
    Youdim S.
    Cancer Res; 1977 Feb; 37(2):572-7. PubMed ID: 401681
    [Abstract] [Full Text] [Related]

  • 17. Tumor cell-triggered macrophage-mediated suppression of the T-cell cytotoxic response to tumor-associated antigens. I. Characterization of the cell components for induction of suppression.
    Ting CC, Rodrigues D.
    J Natl Cancer Inst; 1982 Oct; 69(4):867-72. PubMed ID: 6214653
    [Abstract] [Full Text] [Related]

  • 18. Mechanisms of specific and non-specific tumour immunity after azathioprine treatment of mice.
    Purves EC.
    Clin Exp Immunol; 1975 Nov; 22(2):348-58. PubMed ID: 813934
    [Abstract] [Full Text] [Related]

  • 19. Suppressor cells in the spleen of tumor-allosensitized mice.
    Argyris BF.
    Cancer Res; 1977 Sep; 37(9):3390-9. PubMed ID: 141979
    [Abstract] [Full Text] [Related]

  • 20. Chemoimmunotherapy of L1210 leukemia with adriamycin, cyclophosphamide, and OK-432, and their effects on the generation of antitumor immunity.
    Ujiie T.
    Jpn J Cancer Res; 1987 Jul; 78(7):737-47. PubMed ID: 3114200
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.